Fungal infections in immunocompromised critically ill patients

被引:3
|
作者
Garnacho-Montero, Jose [1 ]
Barrero-Garcia, Irene [1 ]
Leon-Moya, Cristina [1 ]
机构
[1] Hosp Univ Virgen Macarena, Unidad Clin Cuidados Intens, Seville, Spain
来源
JOURNAL OF INTENSIVE MEDICINE | 2024年 / 4卷 / 03期
关键词
Invasive aspergillosis; Immunocompromised patient; Critically ill patient; Antifungal; Invasive candidiasis; Pneumocystis jirovecii; BRONCHOALVEOLAR LAVAGE FLUID; PNEUMOCYSTIS-CARINII-PNEUMONIA; BETA-D-GLUCAN; INVASIVE ASPERGILLOSIS; RESPIRATORY-INFECTIONS; JIROVECII PNEUMONIA; DISEASES SOCIETY; 2016; UPDATE; DIAGNOSIS; CANDIDIASIS;
D O I
10.1016/j.jointm.2024.01.005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 50 条
  • [21] (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people
    White, Sandra K.
    Schmidt, Robert L.
    Walker, Brandon S.
    Hanson, Kimberly E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (07):
  • [22] Clinical use and tolerability of voriconazole in the treatment of fungal infections in critically ill patients
    Alvarez-Lerma, F
    Nicolás-Arfelis, JM
    Rodriguez-Borregan, JC
    Díaz-Regañón, J
    Sa-Borges, M
    García-López, F
    Allepuz-Palau, A
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (04) : 417 - 427
  • [23] Fungal Infections in Critically Ill COVID-19 Patients: Inevitabile Malum
    Rovina, Nikoletta
    Koukaki, Evangelia
    Romanou, Vasiliki
    Ampelioti, Sevasti
    Loverdos, Konstantinos
    Chantziara, Vasiliki
    Koutsoukou, Antonia
    Dimopoulos, George
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [24] Severe mold fungal infections in critically ill patients with COVID-19
    Koulenti, Despoina
    Paramythiotou, Elisabeth
    Almyroudi, Maria Panagiota
    Karvouniaris, Marios
    Markou, Nikolaos
    Paranos, Paschalis
    Routsi, Christina
    Meletiadis, Joseph
    Blot, Stijn
    FUTURE MICROBIOLOGY, 2024, 19 (08) : 697 - 714
  • [25] Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
    Raffaelli, Francesca
    Tanzarella, Eloisa Sofia
    De Pascale, Gennaro
    Tumbarello, Mario
    JOURNAL OF FUNGI, 2022, 8 (04)
  • [26] EPIDEMIOLOGY OF FUNGAL INFECTIONS IN CRITICALLY ILL PATIENTS: ANALYSIS OF A LARGE OBSERVATIONAL DATABASE
    Bateman, Marjorie
    Kheir, Fayez
    CHEST, 2019, 156 (04) : 840A - 840A
  • [27] Fungal load in critically ill patients
    Ludewig, K.
    Otto, G. P.
    Hutagalung, R.
    Brunkhorst, F. M.
    INFECTION, 2009, 37 : 44 - 44
  • [28] Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
    Bele, Nicolas
    Darmon, Michael
    Coquet, Isaline
    Feugeas, Jean-Paul
    Legriel, Stephane
    Adaoui, Nadir
    Schlemmer, Benoit
    Azoulay, Elie
    BMC INFECTIOUS DISEASES, 2011, 11
  • [29] Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients
    Nicolas Bele
    Michael Darmon
    Isaline Coquet
    Jean-Paul Feugeas
    Stéphane Legriel
    Nadir Adaoui
    Benoît Schlemmer
    Élie Azoulay
    BMC Infectious Diseases, 11
  • [30] Is this critically ill patient immunocompromised?
    Pene, Frederic
    Pickkers, Peter
    Hotchkiss, Richard S.
    INTENSIVE CARE MEDICINE, 2016, 42 (06) : 1051 - 1054